selected publications
-
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.
The American journal of pathology.
2020
Academic Article
GET IT
Times cited: 183 -
Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307.
mBio.
2017
Academic Article
GET IT
Times cited: 75 -
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
PloS one.
2016
Academic Article
GET IT
Times cited: 5 -
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.
Cytokine.
2014
Review
GET IT
Times cited: 665 - Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance. Journal of neuroimmunology. 2014 Academic Article GET IT
-
Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.
Journal of neuroimmunology.
2014
Review
GET IT
Times cited: 24 -
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
Journal of neuroimmunology.
2012
Academic Article
GET IT
Times cited: 26 -
Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
Journal of neuroinflammation.
2011
Academic Article
GET IT
Times cited: 32 -
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.
Cellular and molecular neurobiology.
2011
Academic Article
GET IT
Times cited: 39 -
Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
PloS one.
2011
Academic Article
GET IT
Times cited: 68 -
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.
European journal of immunology.
2010
Academic Article
GET IT
Times cited: 94 -
Reversible alopecia associated with glatiramer acetate.
Archives of neurology.
2010
Letter
GET IT
Times cited: 6 -
Translational research in neurology and neuroscience 2010: multiple sclerosis.
Archives of neurology.
2010
Review
GET IT
Times cited: 15 -
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
Vaccine.
2010
Academic Article
GET IT
Times cited: 29 -
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling.
Brain : a journal of neurology.
2010
Academic Article
GET IT
Times cited: 29 -
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
JAMA.
2009
Academic Article
GET IT
Times cited: 46 -
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Nature immunology.
2009
Academic Article
GET IT
Times cited: 580 -
Direct and consensual murine pupillary reflex metrics: establishing normative values.
Autonomic neuroscience : basic & clinical.
2009
Academic Article
GET IT
Times cited: 20 -
Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
2009
GET IT
Times cited: 69 -
200 years after Darwin.
JAMA.
2009
Academic Article
GET IT
Times cited: 2 -
200 years after Darwin.
Archives of neurology.
2009
Editorial Article
GET IT
Times cited: 1 -
Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
Archives of neurology.
2009
Letter
GET IT
Times cited: 3 -
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
PloS one.
2009
Academic Article
GET IT
Times cited: 44 -
Immunologic mechanisms of multiple sclerosis.
Neuroimaging clinics of North America.
2008
Review
GET IT
Times cited: 23 -
Quinpramine is a novel compound effective in ameliorating brain autoimmune disease.
Experimental neurology.
2008
Academic Article
GET IT
Times cited: 11 -
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.
Archives of neurology.
2008
Academic Article
GET IT
Times cited: 129 -
DNA-based vaccines: the future of multiple sclerosis therapy?.
Expert review of neurotherapeutics.
2008
Review
GET IT
Times cited: 10 -
DNA plasmid vaccination for multiple sclerosis.
Archives of neurology.
2007
Editorial Article
GET IT
Times cited: 5 -
Prion proteins: physiological functions and role in neurological disorders.
Journal of the neurological sciences.
2007
Review
GET IT
Times cited: 29 -
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
The Journal of experimental medicine.
2006
Academic Article
GET IT
Times cited: 257 -
Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.
Proceedings of the National Academy of Sciences of the United States of America.
2005
Academic Article
GET IT
Times cited: 81 -
CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance.
Journal of immunology (Baltimore, Md. : 1950).
2004
Academic Article
GET IT
Times cited: 27 -
Notch 1 signaling regulates peripheral T cell activation.
Immunity.
2004
Academic Article
GET IT
Times cited: 135 -
Functional activation of myelin-specific T cells by virus-induced molecular mimicry.
Journal of immunology (Baltimore, Md. : 1950).
2002
Academic Article
GET IT
Times cited: 56 -
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
European journal of immunology.
2002
Academic Article
GET IT
Times cited: 99 -
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
The Journal of clinical investigation.
2001
Academic Article
GET IT
Times cited: 107 -
Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases.
Advances in experimental medicine and biology.
2001
Review
GET IT
Times cited: 22 -
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
Journal of neuroimmunology.
2000
Academic Article
GET IT
Times cited: 50 -
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950).
2000
Academic Article
GET IT
Times cited: 177 -
The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Immunological reviews.
1998
Review
GET IT
Times cited: 154 -
Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950).
1998
Academic Article
GET IT
Times cited: 60